NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.

Abstract

INTRODUCTION Crohn's disease (CD) is a chronic, disabling disease of the gastrointestinal tract that mostly affects young adults. Despite extensive research, the pathogenesis of CD is still not completely understood. It is thought that an abnormal mucosal immune response is elicited towards the luminal microbiota in genetically predisposed persons. Genome… (More)
DOI: 10.1080/14728222.2017.1397627

Topics

2 Figures and Tables

Cite this paper

@article{Bruyn2017NOD2AB, title={NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.}, author={Magali de Bruyn and S{\'e}verine Vermeire}, journal={Expert opinion on therapeutic targets}, year={2017}, volume={21 12}, pages={1123-1139} }